New FDA Rule on Generic Drugs Could Hike Costs $4 Billion per Year

A proposed FDA rule on labeling generic drugs could increase generic drug-makers’ exposure to product-liability lawsuits. This could add $4 billion a year to the cost of generic drugs, according to Scott Gottlieb, MD, and colleagues. A new regulation proposed by the Food and Drug Administration will compel generic drug makers to update their drug […]



via John Goodman's Health Policy Blog http://ift.tt/1oUak6a